Prognostic factors of survival in patients with gastric cancer: a retrospective study in the Aktobe region for 2010-2024.
DOI:
https://doi.org/10.3329/bjms.v24i2.81720Keywords:
Gastric cancer, prognostic factors, five-year survival, lauren classification, Kaplan-Meier.Abstract
Relevance Gastric cancer (GC) remains a leading cause of cancer mortality, with survival rates heavily dependent on early detection. Most cases are diagnosed at advanced stages, resulting in poor prognoses and low 5-year survival rates. Accurate survival estimates are essential for assessing treatment effectiveness and guiding healthcare strategies. However, data collection delays hinder timely analysis. Model-based period analysis addresses this issue, enabling real-time survival estimates and forecasting trends to improve patient outcomes and cancer management. Aims To evaluate the prognostic factors influencing survival in patients with gastric cancer, considering demographic, clinical, and histopathological characteristics in the Aktobe region from 2010 to 2024. Methods A retrospective study was conducted using data from 1859 GC patients registered in the Aktobe Cancer Registry. Survival analysis was performed using Kaplan-Meier estimation, log-rank tests, and Cox proportional hazards models. Factors such as age, sex, tumor stage, histological subtype, tumor location, and ethnicity were analyzed for their impact on survival. Results The overall five-year survival rate was 21.5%. Advanced tumor stage was the most significant prognostic factor, with stage IV patients having significantly worse survival than stage I (p = 0.0124). Ethnicity was associated with survival differences, with non-Kazakh patients showing a higher risk of mortality (p = 0.0334). However, age, sex, tumor location, and Lauren classification did not show a statistically significant impact on survival. Patients with localized GC had significantly better survival outcomes compared to those with advanced disease (p < 0.001). Conclusion Tumor stage and ethnicity were identified as key prognostic factors affecting GC survival, while other clinical variables had less predictive value. These findings highlight the need for improved early detection strategies and targeted interventions to enhance patient outcomes. Further research incorporating molecular profiling may improve individualized treatment approaches.
Bangladesh Journal of Medical Science Vol. 24 No. 02 April’25 Page : 538-553
Downloads
69
66
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Anar Tulyayeva, Perizat Aitmaganbet, Lunara Ishimova, Marzhan Aitmaganbet, Nurgul Kereyeva, Nurbek Azbergenov, Talshyn Nurulla
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish in the Bangladesh Journal of Medical Science agree to the following terms that:
- Authors retain copyright and grant Bangladesh Journal of Medical Science the right of first publication of the work.
Articles in Bangladesh Journal of Medical Science are licensed under a Creative Commons Attribution 4.0 International License CC BY-4.0.This license permits use, distribution and reproduction in any medium, provided the original work is properly cited.- Authors are able to enter into separate, additional contractual arrangements for the distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted to post their work online (e.g., in institutional repositories or on their website) as it can lead to productive exchanges, as well as greater citation of published work.
